714.93美元2.83(0.4%)
2024/11/29更新
績效 / 1月2.29%
3月8.31%
1年10.54%
晨星評等 - 1.現金0.00%
- 2.股票25.91%
- 3.債券0.00%
- 4.其他74.09%
- 1.美國74.09%
- 2.歐洲不包含歐元區17.33%
- 3.英國3.60%
- 4.日本2.81%
- 5.大洋洲1.02%
- 1.Eli Lilly and Co8.64%
- 2.UnitedHealth Group Inc8.56%
- 3.Novo Nordisk AS Class B6.18%
- 4.Roche Holding AG5.92%
- 5.Merck & Co Inc5.91%
- 6.Gilead Sciences Inc5.06%
- 7.Vertex Pharmaceuticals Inc4.37%
- 8.Intuitive Surgical Inc4.01%
- 9.Johnson & Johnson3.69%
- 10.Regeneron Pharmaceuticals Inc3.64%
- 1.現金0.00%
- 2.股票25.91%
- 3.債券0.00%
- 4.其他74.09%
- 1.美國74.09%
- 2.歐洲不包含歐元區17.33%
- 3.英國3.60%
- 4.日本2.81%
- 5.大洋洲1.02%
- 1.Eli Lilly and Co8.64%
- 2.UnitedHealth Group Inc8.56%
- 3.Novo Nordisk AS Class B6.18%
- 4.Roche Holding AG5.92%
- 5.Merck & Co Inc5.91%
- 6.Gilead Sciences Inc5.06%
- 7.Vertex Pharmaceuticals Inc4.37%
- 8.Intuitive Surgical Inc4.01%
- 9.Johnson & Johnson3.69%
- 10.Regeneron Pharmaceuticals Inc3.64%